CABALETTA BIO INC. - COMMON STOCK
4.1100
13-9月-24 15:59:59
15 分の遅延
株式
+0.0800
+1.99%
本日の幅
4.0500 - 4.3088
ISIN
N/A
ソース
NASDAQ
-
01 11 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the Chardan 5th Annual Genetic Medicines Conference
28 9 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
Cabaletta Bio Announces Appointment of Michael Gerard as General Counsel
07 9 2021 08:00:03 提供 Nasdaq GlobeNewswire
-
18 8 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Cabaletta Bio Reports Second Quarter 2021 Financial Results and Provides Business Update
05 8 2021 07:30:01 提供 Nasdaq GlobeNewswire
-
Cabaletta Bio Appoints Biopharmaceutical Leader Scott Brun, M.D. to Board of Directors
28 6 2021 08:00:00 提供 Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the Jefferies Healthcare Conference
27 5 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
Cabaletta Bio Reports First Quarter 2021 Financial Results and Provides New Pipeline Updates
03 5 2021 07:05:00 提供 Nasdaq GlobeNewswire
-
Cabaletta Bio Reports Acute Safety Data from the First Dose Cohort in DesCAARTes™ Trial
03 5 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 20th Annual Needham Healthcare Conference
07 4 2021 08:00:02 提供 Nasdaq GlobeNewswire
-
16 3 2021 07:30:01 提供 Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in Upcoming Investor Conferences in March
23 2 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
07 1 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in Upcoming January Investor Conferences
04 1 2021 08:00:00 提供 Nasdaq GlobeNewswire